$SFES
SAFEGUARD SCIENTIFICS INC

2013 Q2 Form 10-Q Financial Statement

#000156459013000122 Filed on July 26, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.700M $5.100M
YoY Change 31.37% -8.93%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $6.700M $5.100M
YoY Change 31.37% -8.93%
Operating Profit -$6.715M -$5.148M
YoY Change 30.44% -7.58%
Interest Expense -$18.70M -$6.100M
YoY Change 206.56% -104.76%
% of Operating Profit
Other Income/Expense, Net -$2.724M $4.819M
YoY Change -156.53% -721.81%
Pretax Income -$28.12M -$10.14M
YoY Change 177.43% -108.32%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$28.12M -$10.14M
YoY Change 177.43% -108.32%
Net Earnings / Revenue
Basic Earnings Per Share -$1.33 -$0.48
Diluted Earnings Per Share -$1.33 -$0.48
COMMON SHARES
Basic Shares Outstanding 21.13M shares 20.93M
Diluted Shares Outstanding 21.13M shares 20.93M

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $173.0M $202.2M
YoY Change -14.44% -20.61%
Cash & Equivalents $102.7M $58.73M
Short-Term Investments $70.20M $143.5M
Other Short-Term Assets $1.300M $13.10M
YoY Change -90.08% 3.97%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $174.3M $215.3M
YoY Change -19.04% -19.42%
LONG-TERM ASSETS
Property, Plant & Equipment $164.0K $200.0K
YoY Change -18.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $102.7M $163.6M
YoY Change -37.22% 18.98%
Other Assets $3.077M $6.400M
YoY Change -51.92% -36.63%
Total Long-Term Assets $161.8M $177.6M
YoY Change -8.89% 20.16%
TOTAL ASSETS
Total Short-Term Assets $174.3M $215.3M
Total Long-Term Assets $161.8M $177.6M
Total Assets $336.1M $392.9M
YoY Change -14.45% -5.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $203.0K $200.0K
YoY Change 1.5% -33.33%
Accrued Expenses $3.631M $6.400M
YoY Change -43.27% -15.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $500.0K
YoY Change
Total Short-Term Liabilities $7.938M $6.600M
YoY Change 20.27% -16.46%
LONG-TERM LIABILITIES
Long-Term Debt $49.00M $46.00M
YoY Change 6.52% 1.32%
Other Long-Term Liabilities $3.862M $4.000M
YoY Change -3.45% -4.76%
Total Long-Term Liabilities $3.862M $50.00M
YoY Change -92.28% 0.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.938M $6.600M
Total Long-Term Liabilities $3.862M $50.00M
Total Liabilities $60.77M $56.70M
YoY Change 7.18% -1.39%
SHAREHOLDERS EQUITY
Retained Earnings -$544.1M
YoY Change
Common Stock $819.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $275.3M $336.2M
YoY Change
Total Liabilities & Shareholders Equity $336.1M $392.9M
YoY Change -14.45% -5.33%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$28.12M -$10.14M
YoY Change 177.43% -108.32%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$4.600M -$2.900M
YoY Change 58.62% -6.45%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $30.40M -$28.80M
YoY Change -205.56% -125.97%
Cash From Investing Activities $30.40M -$28.90M
YoY Change -205.19% -126.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -100.0K 400.0K
YoY Change -125.0% 100.0%
NET CHANGE
Cash From Operating Activities -4.600M -2.900M
Cash From Investing Activities 30.40M -28.90M
Cash From Financing Activities -100.0K 400.0K
Net Change In Cash 25.70M -31.40M
YoY Change -181.85% -129.07%
FREE CASH FLOW
Cash From Operating Activities -$4.600M -$2.900M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$4.600M -$2.900M
YoY Change 58.62% -6.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Trading Symbol
TradingSymbol
SFE
dei Entity Registrant Name
EntityRegistrantName
SAFEGUARD SCIENTIFICS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000086115
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26976963
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102732000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66029000
CY2012Q4 us-gaap Escrow Deposit
EscrowDeposit
6434000
CY2013Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
70231000
CY2012Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
110957000
CY2013Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
6000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1334000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2408000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
174303000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
185838000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
164000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193000
CY2013Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
143100000
CY2012Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
148639000
CY2013Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
8310000
CY2012Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
7085000
CY2013Q2 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
18000
CY2012Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
58000
CY2013Q2 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
7146000
CY2012Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
29059000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3077000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3272000
CY2013Q2 us-gaap Assets
Assets
336118000
CY2012Q4 us-gaap Assets
Assets
374144000
CY2013Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
470000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
203000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
610000
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3634000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4050000
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3631000
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2601000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7938000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7261000
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3862000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3921000
CY2013Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
48970000
CY2012Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
48991000
CY2013Q2 us-gaap Liabilities
Liabilities
60770000
CY2012Q4 us-gaap Liabilities
Liabilities
60173000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
2098000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2097000
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
817384000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
815946000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-544134000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-504072000
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
275348000
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
313971000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
336118000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
374144000
CY2013Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
19363000
CY2012Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
20972000
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20977000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20968000
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20977000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20968000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6715000
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5148000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12089000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9891000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6715000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5148000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12089000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9891000
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2724000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4819000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1967000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7903000
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
790000
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
595000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1524000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1494000
CY2013Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1074000
CY2012Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1456000
us-gaap Interest Expense Debt
InterestExpenseDebt
2143000
us-gaap Interest Expense Debt
InterestExpenseDebt
2908000
CY2013Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-18400000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.33
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.95
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.33
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2012Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8947000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-25387000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-16395000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28123000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10137000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40062000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19797000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2013Q2 us-gaap Profit Loss
ProfitLoss
-28123000
CY2012Q2 us-gaap Profit Loss
ProfitLoss
-10137000
us-gaap Profit Loss
ProfitLoss
-40062000
us-gaap Profit Loss
ProfitLoss
-19797000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.95
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21128000
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20927000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21119000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20903000
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-26000
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
734000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-40000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5800000
CY2013Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
26000
CY2012Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
144000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
40000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
144000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28123000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9259000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40062000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13853000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11540000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9624000
us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
1403000
us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
11061000
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
8100000
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
5141000
sfe Origination Fees On Loans
OriginationFeesOnLoans
42000
sfe Origination Fees On Loans
OriginationFeesOnLoans
46000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
15131000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
16190000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
29913000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
141997000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
92552000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
133751000
us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
928000
us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
3144000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
21000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
25000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
6434000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
48194000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15351000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
43000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
92000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
513000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
513000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
36703000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-24462000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83187000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58725000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
92000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
49000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1298000
CY2013Q2 us-gaap Equity Method Investments
EquityMethodInvestments
102711000
CY2012Q4 us-gaap Equity Method Investments
EquityMethodInvestments
106741000
CY2013Q2 us-gaap Cost Method Investments
CostMethodInvestments
15514000
CY2012Q4 us-gaap Cost Method Investments
CostMethodInvestments
12634000
CY2013Q2 us-gaap Advances To Affiliate
AdvancesToAffiliate
5512000
CY2012Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
8292000
CY2013Q2 us-gaap Convertible Debt
ConvertibleDebt
49440000
CY2012Q4 us-gaap Convertible Debt
ConvertibleDebt
48991000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
922000
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
846000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1298000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1229000
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21128000
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20927000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21119000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20903000
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21128000
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20927000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21119000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20903000
CY2013Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
3.93
CY2012Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
3.93
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
3.93
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
3.93
CY2013Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
18.80
CY2012Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
18.80
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
18.80
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
18.80
CY2013Q2 sfe Partner Companies Not Consolidated In Financial Statements
PartnerCompaniesNotConsolidatedInFinancialStatements
20
CY2013Q2 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
3800000
CY2008Q2 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
6400000
sfe Lease Guarantee Expiration Year
LeaseGuaranteeExpirationYear
2016
sfe Future Annual Payment To Chairman And Chief Executive Officer
FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer
650000

Files In Submission

Name View Source Status
0001564590-13-000122-index-headers.html Edgar Link pending
0001564590-13-000122-index.html Edgar Link pending
0001564590-13-000122.txt Edgar Link pending
0001564590-13-000122-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
sfe-10q_20130630.htm Edgar Link pending
sfe-20130630.xml Edgar Link completed
sfe-20130630.xsd Edgar Link pending
sfe-20130630_cal.xml Edgar Link unprocessable
sfe-20130630_def.xml Edgar Link unprocessable
sfe-20130630_lab.xml Edgar Link unprocessable
sfe-20130630_pre.xml Edgar Link unprocessable
sfe-ex10_20130629206.htm Edgar Link pending
sfe-ex10_20130629207.htm Edgar Link pending
sfe-ex31_20130629211.htm Edgar Link pending
sfe-ex31_20130629212.htm Edgar Link pending
sfe-ex32_20130629209.htm Edgar Link pending
sfe-ex32_20130629210.htm Edgar Link pending
Show.js Edgar Link pending